Expansion of monocytic myeloid-derived suppressor cells in endometriosis patients: A pilot study
article
OA: closed
CC0
⤵ 17 in-corpus citations
AI-generated summary
This pilot study investigated and found an expansion of monocytic myeloid-derived suppressor cells in patients diagnosed with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is a chronic inflammation disease and is closely associated with immune dysregulation. Myeloid-derived suppressor cells (MDSCs) are a negative regulator of the immune system. The aim of this study was to evaluate the possible role of MDSCs in endometriosis patients. We collected the peripheral blood and peritoneal fluid from endometriosis patients and controls and analyzed M-MDSCs level using specific monoclonal antibodies recognizing HLA-DR, CD33, CD11b, CD14 markers by flow cytometry. We found that there existed abnormal expansion of monocytic MDSCs (M-MDSCs) (HLA-DR-/lowCD33+CD11b+ CD14+) in peripheral blood and peritoneal fluid of patients with endometriosis. Functional studies revealed that M-MDSCs from endometriosis patients significantly suppressed T-cell responses and produced high level of reactive oxygen species (ROS). The elevation of M-MDSCs from endometriosis patients may contribute to the disease progression.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (36)
- Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and late-staged endometriosis via openalex
- Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? via openalex
- Pathogenesis of endometriosis: The role of initial infection and subsequent sterile inflammation (Review) via openalex
- Pathophysiology and Immune Dysfunction in Endometriosis via openalex
- Possible effects of endometriosis-related immune events on reproductive function via openalex
- Regulatory T cells and other leukocytes in the pathogenesis of endometriosis via openalex
- Role of cytokines in endometriosis via openalex
- Treating endometriosis as an autoimmune disease via openalex
- W2022041162 via openalex
- W2022657772 via openalex
- W2042989205 via openalex
- W2061424909 via openalex
- W2063553068 via openalex
- W2077141971 via openalex
- W2082767963 via openalex
- W2091341060 via openalex
- W2097501793 via openalex
- W2107047049 via openalex
- W2152026308 via openalex
- W2152508754 via openalex
- W2159228424 via openalex
- W2163457225 via openalex
- W2168595347 via openalex
- W2317851740 via openalex
- W2463361585 via openalex
- W2477008945 via openalex
- W4211081176 via openalex
- W1829383857 via openalex
- W6677797721 via openalex
- W1864128415 via openalex
- W1940828074 via openalex
- W1976310228 via openalex
- W1978621486 via openalex
- W2004150448 via openalex
- W2015642763 via openalex
- W2019637656 via openalex
Cited by (20)
- p16 Beyond Senescence: Cancer Biology Lessons Applied to Endometriosis 2026
- Pro-EGCG suppresses endometriosis progression via regulating monocytic myeloid-derived suppressor cells 2026
- Immune-epigenetic-metabolic crosstalk: attempting to unravel the multidimensional mechanisms of immune evasion in endometriosis 2026
- Current Understanding of Endometriosis Pathophysiology and Future Perspectives 2025
- Molecular links in endometriosis pathogenesis as targets for diagnosis and targeted therapy: a review 2025
- An integrated multi-tissue approach for endometriosis candidate biomarkers: a systematic review 2024
- Immune Checkpoints in Endometriosis-A New Insight in the Pathogenesis 2024
- The role of CD8+ T cells in endometriosis: a systematic review 2023
- Myeloid-derived suppressor cells: A new emerging player in endometriosis 2023
- Endometriosis through an immunological lens: a pathophysiology based in immune dysregulation 2022
- Endometriosis and autoimmunity: Can autoantibodies be used as a non-invasive early diagnostic tool? 2021
- The Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Development and/or Progression of Endometriosis-State of the Art 2021
- Circulating miRNAs Related to Epithelial–Mesenchymal Transitions (EMT) as the New Molecular Markers in Endometriosis 2021
- Reduction of myeloid derived suppressor cells by inhibiting Notch pathway prevents the progression of endometriosis in mice model 2020
- CD4+/CD8+ mucosa-associated invariant T cells foster the development of endometriosis: a pilot study 2019
- The role of monocytic myeloid‐derived suppressor cells in the pathogenesis of endometriosis 2019
- Anti-inflammatory cytokines in endometriosis 2019
- CD33<sup>+</sup>CD14<sup>+</sup>CD11b<sup>+</sup>HLA‐DR<sup>−</sup> monocytic myeloid‐derived suppressor cells recruited and activated by CCR9/CCL25 are crucial for the pathogenic progression of endometriosis 2018
- The role of selected populations of immune cells in the pathogenesis of endometriosis 2018
- Alteration of Myeloid-Derived Suppressor Cells, Chronic Inflammatory Cytokines, and Exosomal miRNA Contribute to the Peritoneal Immune Disorder of Patients With Endometriosis 2018
Source provenance
- europepmc
- last seen: 2026-09-09T06:15:24.302764+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:31.759405+00:00
- unpaywall
- last seen: 2026-09-09T06:31:01.691765+00:00
License: CC0
· commercial use OK